# Supplied Claude Phase 1 closeout review — 2026-10-25

Source: the readiness/limitations review supplied by the user in this conversation on 2026-10-25.
This records that supplied review, not a new Claude invocation or an independently retrieved
approval. Its statement that the user already accepted items 1–5 on that date is the provenance
for recording their acceptance. Items 6–8 were recommendations at receipt; subsequent explicit user decisions are recorded below.
The Codex bot review on PR #7 is separate and is not Claude evidence.

## Already accepted, as recorded in the supplied review

1. Stop or background while the model loads: covered by unit tests only, because loading is too
   fast to interrupt on these devices.
2. Stop while the permission prompt is open: blocked by Safari's dialog on the iPad and not checked
   on the iPhone. Covered by a unit test.
3. Network inspection, deployed headers and page HTML: not inspected. The security policy blocks
   other sites but still allows requests back to the app's own site.
4. External interruption: not tested on a device (no second device or person available).
5. Historical S1/S2: unexplained, and not seen again since the diagnostics and security policy were
   added.

Acceptance date for these five limitations: **2026-10-25**, attributed to the user-supplied review.
Acceptance is a scope/risk decision, not a physical test pass. CSP specifically restricts off-origin
script/connection sources; it is not a guarantee against every exfiltration mechanism.

## Recommendations at receipt — subsequently decided below

6. Storage denial: the review reports that the app worked with Block All Cookies enabled, but
   there is no evidence Safari refused storage. Actual refusal is covered only by the automated
   blocked-storage test. Recommendation: accept the physical evidence gap as a limit.
7. Diagnostics coverage: only the main page after instrumentation loads. Other tabs, frames and
   browser internals are not covered. One full pasted log has no device identity, and the other
   device's equivalent behavior is user-reported. Recommendation: accept this evidence limit.
8. Diagnostics shipping: the script is fetched on every load, activates only with `?diag=1`, stays
   local and is tested. Recommendation: keep it opt-in through Phase 2 for device testing, then
   decide before the first production deployment. No production deployment is authorized; the
   deferred production decision should not block Phase 1 closeout.

The Block All Cookies observation is supplied through this review, not a new directly inspected
session, and no device-specific attribution or proof of actual storage denial is added.
See [the closeout](../phases/PHASE_1_CLOSEOUT.md) for decisions and evidence links.

## Subsequent explicit user decisions — 2026-10-25 UTC

The user directly accepted limitations 6 and 7, approved proposal 8 and approved Phase 1 closeout
with the documented limits. Actual Safari storage denial remains untested; automated coverage
is sufficient for that closeout. Diagnostic coverage/provenance acceptance does not explain
S1/S2 or establish absence of uploads. Existing opt-in diagnostics remain for device testing,
including through Phase 2 only if separately authorized. Production inclusion is to be decided
before the first production deployment. The exact approval is quoted in the closeout document.

No PR merge, deployment, protection/automatic-deployment change or Phase 2 was authorized. These
are direct user decisions after the supplied review, not a new Claude review or added test evidence.
